Emerging Therapeutic Strategies for COVID-19 Patients

Shudong Zhu; Xialing Guo; Kyla Geary; Dianzheng Zhang

Emerging Therapeutic Strategies for COVID-19 Patients

Shudong Zhu, Xialing Guo, Kyla Geary, Dianzheng Zhang

Department of Bio-Medical Sciences (PCOM)

Research output: Contribution to journal › Article › peer-review

Abstract

Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.

Original language	American English
Journal	Discoveries
Volume	8
State	Published - Mar 12 2020

Keywords

2019-nCoV
COVID-19
Coronavirus
SARS-COV-2
abidol
chloroquine phosphate
lopinavir/ritonavir
plasma
remdesivir

Disciplines

Infectious Disease
Medicine and Health Sciences

Access to Document

Emerging Therapeutic Strategies for COVID-19 PatientsFinal published version, 294 KBLicense: CC BY

Cite this

@article{dc60b2916d4c47589374a1441bcf1749,

title = "Emerging Therapeutic Strategies for COVID-19 Patients",

abstract = " Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.",

keywords = "2019-nCoV, COVID-19, Coronavirus, SARS-COV-2, abidol, chloroquine phosphate, lopinavir/ritonavir, plasma, remdesivir",

author = "Shudong Zhu and Xialing Guo and Kyla Geary and Dianzheng Zhang",

year = "2020",

month = mar,

day = "12",

language = "American English",

volume = "8",

journal = "Discoveries",

}

TY - JOUR

T1 - Emerging Therapeutic Strategies for COVID-19 Patients

AU - Zhu, Shudong

AU - Guo, Xialing

AU - Geary, Kyla

AU - Zhang, Dianzheng

PY - 2020/3/12

Y1 - 2020/3/12

N2 - Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.

AB - Over 100,000 cases of COVID-19 patients infected with the novel coronavirus SARS-COV-2 have been reported worldwide in approximately 2 months, resulting in over 3000 deaths. Potential therapeutic strategies, including remdesivir, chloroquine phosphate, abidol, lopinavir/ritonavir, plasma, antibody, vaccine and stem cells are discussed in this review. With the number of patients increasing daily, there is an urgent need for effective therapeutic intervention.

KW - 2019-nCoV

KW - COVID-19

KW - Coronavirus

KW - SARS-COV-2

KW - abidol

KW - chloroquine phosphate

KW - lopinavir/ritonavir

KW - plasma

KW - remdesivir

UR - https://digitalcommons.pcom.edu/scholarly_papers/2053

M3 - Article

VL - 8

JO - Discoveries

JF - Discoveries

ER -

Emerging Therapeutic Strategies for COVID-19 Patients

Abstract

Keywords

Disciplines

Access to Document

Other files and links

Cite this